Potent In Vitro Antiproliferative Synergism of Combinations of Ergosterol Biosynthesis Inhibitors against Leishmania amazonensis

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Antimicrobial Agents and Chemotherapy

• Publication date

  2015-08-03

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1128/AAC.01150-15PMID 26239973PMCID PMC4576079
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Sterol Biosynthesis Pathway as an Alternative for the Anti-Protozoan Parasite Chemotherapy.

  2015cited by this paper
• Targeting Ergosterol Biosynthesis in Leishmania donovani: Essentiality of Sterol 14alpha-demethylase

  2015cited by this paper
• VFV as a New Effective CYP51 Structure-Derived Drug Candidate for Chagas Disease and Visceral Leishmaniasis.

  2015cited by this paper
• Squalene Synthase As a Target for Chagas Disease Therapeutics

  2014cited by this paper
• Studies on the Antileishmanial Mechanism of Action of the Arylimidamide DB766: Azole Interactions and Role of CYP5122A1

  2014cited by this paper
• In vitro interaction between paromomycin sulphate and four drugs with leishmanicidal activity against three New World Leishmania species.

  2014cited by this paper
• Synergy Testing of FDA-Approved Drugs Identifies Potent Drug Combinations against Trypanosoma cruzi

  2014cited by this paper
• In Vitro Activity of the Antifungal Azoles Itraconazole and Posaconazole against Leishmania amazonensis

  2013cited by this paper
• Trypanosoma cruzi Response to Sterol Biosynthesis Inhibitors: Morphophysiological Alterations Leading to Cell Death

  2013cited by this paper
• Leishmaniasis Worldwide and Global Estimates of Its Incidence

  2012cited by this paper
• Management of trypanosomiasis and leishmaniasis

  2012influential reference
• Cutaneous and mucocutaneous leishmaniasis.

  2012cited by this paper
• Posaconazole Exposure-Response Relationship: Evaluating the Utility of Therapeutic Drug Monitoring

  2012cited by this paper
• Miltefosine: a review of its pharmacology and therapeutic efficacy in the treatment of leishmaniasis.

  2012cited by this paper
• Leishmaniasis: current status of available drugs and new potential drug targets.

  2012cited by this paper
• Two squalene synthase inhibitors, E5700 and ER-119884, interfere with cellular proliferation and induce ultrastructural and lipid profile alterations in a Candida tropicalis strain resistant to fluconazole, itraconazole, and amphotericin B

  2011cited by this paper
• Successful Treatment of Old World Cutaneous Leishmaniasis Caused by Leishmania infantum with Posaconazole

  2011cited by this paper
• Host cell lipid bodies triggered by Trypanosoma cruzi infection and enhanced by the uptake of apoptotic cells are associated with prostaglandin E₂ generation and increased parasite growth.

  2011cited by this paper
• Antiproliferative, Ultrastructural, and Physiological Effects of Amiodarone on Promastigote and Amastigote Forms of Leishmania amazonensis

  2011cited by this paper
• Comparison of short-course multidrug treatment with standard therapy for visceral leishmaniasis in India: an open-label, non-inferiority, randomised controlled trial.

  2011cited by this paper
• Lipid Bodies in Inflammatory Cells

  2011cited by this paper
• New insights in Chagas disease treatment

  2010cited by this paper
• Specific chemotherapy of Chagas disease: relevance, current limitations and new approaches.

  2010cited by this paper
• Ergosterol biosynthesis and drug development for Chagas disease.

  2009cited by this paper
• Amiodarone and Miltefosine Act Synergistically against Leishmania mexicana and Can Induce Parasitological Cure in a Murine Model of Cutaneous Leishmaniasis

  2009cited by this paper
• Sterol Biosynthesis Pathway as Target for Anti-trypanosomatid Drugs

  2009cited by this paper
• The life of lipid droplets.

  2009cited by this paper
• Current treatment and drug discovery against Leishmania spp. and Plasmodium spp.: a review.

  2009cited by this paper
• Recent initiatives and strategies to developing new drugs for tropical parasitic diseases

  2008cited by this paper
• New treatment approach in Indian visceral leishmaniasis: single-dose liposomal amphotericin B followed by short-course oral miltefosine.

  2008cited by this paper
• Mitochondria-Dependent Reactive Oxygen Species-Mediated Programmed Cell Death Induced by 3,3′-Diindolylmethane through Inhibition of F0F1-ATP Synthase in Unicellular Protozoan Parasite Leishmania donovani

  2008cited by this paper
• In Vitro Activities of ER-119884 and E5700, Two Potent Squalene Synthase Inhibitors, against Leishmania amazonensis: Antiproliferative, Biochemical, and Ultrastructural Effects

  2008cited by this paper
• Sterol methenyl transferase inhibitors alter the ultrastructure and function of the Leishmania amazonensis mitochondrion leading to potent growth inhibition.

  2007cited by this paper
• Cutaneous leishmaniasis: successful treatment with itraconazole

  2006cited by this paper
• Effects of sterol biosynthesis inhibitors on endosymbiont-bearing trypanosomatids.

  2006cited by this paper
• Amiodarone has intrinsic anti-Trypanosoma cruzi activity and acts synergistically with posaconazole.

  2006cited by this paper
• Antiproliferative and ultrastructural effects of BPQ-OH, a specific inhibitor of squalene synthase, on Leishmania amazonensis.

  2005cited by this paper
• A randomized, double‐blind, placebo‐controlled clinical trial of itraconazole in the treatment of cutaneous leishmaniasis

  2005cited by this paper
• Advances in leishmaniasis.

  2005cited by this paper
• In Vitro and In Vivo Activities of E5700 and ER-119884, Two Novel Orally Active Squalene Synthase Inhibitors, against Trypanosoma cruzi

  2004cited by this paper
• Camptothecin-induced Imbalance in Intracellular Cation Homeostasis Regulates Programmed Cell Death in Unicellular Hemoflagellate Leishmania donovani*

  2004cited by this paper
• Ultrastructural and Biochemical Alterations Induced by 22,26-Azasterol, a Δ24(25)-Sterol Methyltransferase Inhibitor, on Promastigote and Amastigote Forms of Leishmania amazonensis

  2002cited by this paper
• Determination of mitochondrial reactive oxygen species: methodological aspects

  2002cited by this paper
• Squalene synthase as a chemotherapeutic target in Trypanosoma cruzi and Leishmania mexicana.

  2002cited by this paper
• Oral miltefosine for Indian visceral leishmaniasis.

  2002cited by this paper
• In Vitro Activities of Posaconazole (Sch 56592) Compared with Those of Itraconazole and Fluconazole against 3,685 Clinical Isolates of Candida spp. andCryptococcus neoformans

  2001cited by this paper
• The Sterol Composition of Trypanosoma cruzi Changes After Growth in Different Culture Media and Results in Different Sensitivity to Digitonin-Permeabilization

  2001cited by this paper
• Efficacy of the Triazole SCH 56592 againstLeishmania amazonensis and Leishmania donovani in Experimental Murine Cutaneous and Visceral Leishmaniases

  1999cited by this paper
• Leishmaniasis.

  1999cited by this paper
• Antiproliferative Effects and Mechanism of Action of SCH 56592 against Trypanosoma (Schizotrypanum)cruzi: In Vitro and In Vivo Studies

  1998cited by this paper
• Inhibitors of delta24(25) sterol methyltransferase block sterol synthesis and cell proliferation in Pneumocystis carinii

  1997cited by this paper
• Naturally azole-resistant Leishmania braziliensis promastigotes are rendered susceptible in the presence of terbinafine: comparative study with azole-susceptible Leishmania mexicana promastigotes

  1996cited by this paper
• Modification of the sterol composition of Trypanosoma (Schizotrypanum) cruzi epimastigotes by delta 24(25)-sterol methyl transferase inhibitors and their combinations with ketoconazole.

  1995cited by this paper
• Effects of antimycotic azoles on growth and sterol biosynthesis of Leishmania promastigotes.

  1988cited by this paper
• Effects of ketoconazole on sterol biosynthesis by Leishmania mexicana mexicana amastigotes in murine macrophage tumor cells.

  1986cited by this paper
• Effects of ketoconazole on growth and sterol biosynthesis of Leishmania mexicana promastigotes in culture.

  1984cited by this paper
• Synergism between aminoglycosides and cephalosporins with antipseudomonal activity: interaction index and killing curve method

  1982cited by this paper
• Activity of imidazoles against Leishmania tropica in human macrophage cultures.

  1981cited by this paper
• Metabolism of Schizotrypanum cruzi Chagas. I. Effect of culture age and substrate concentration on respiratory rate.

  1960cited by this paper

• Designing drugs against leishmaniasis: is targeting the sterol biosynthesis pathway the answer?

  2025cites this paper
• Synthesis, characterization, DNA interaction studies, and biological evaluation of copper(II) hybrids containing azole drugs and intercalating ligands against neglected diseases.

  2025cites this paper
• Survival of the fittest: How Leishmania evades drug therapy.

  2025cites this paper
• C14DM Ablation Leads to Reduced Tolerance to Plasma Membrane Stress and Increased Drug Sensitivity in Leishmania major

  2025cites this paper
• In Vitro and In Vivo Leishmanicidal Activity of Beauvericin

  2024cites this paper
• Repurposing FDA Approved Drugs against Sterol C-24 methyltransferase of Leishmania donovani: A Dual in silico and in vitro Approach.

  2024cites this paper
• Buparvaquone Induces Ultrastructural and Physiological Alterations Leading to Mitochondrial Dysfunction and Caspase-Independent Apoptotic Cell Death in Leishmania donovani.

  2024cites this paper
• Druggable Sterol Metabolizing Enzymes in Infectious Diseases: Cell Targets to Therapeutic Leads

  2024cites this paper
• Zinc(II)-Sterol Hydrazone Complex as a Potent Anti-Leishmania Agent: Synthesis, Characterization, and Insight into Its Mechanism of Antiparasitic Action

  2023cites this paper
• Profiling Novel Quinuclidine-Based Derivatives as Potential Anticholinesterase Drugs: Enzyme Inhibition and Effects on Cell Viability

  2023cites this paper
• Benzylamines as highly potent inhibitors of the sterol biosynthesis pathway in Leishmania amazonensis leading to oxidative stress and ultrastructural alterations

  2022cites this paper
• Benzyl Farnesyl Amine Mimetics are Potent Inhibitors of the Sterol Biosynthesis Pathway in Leishmania Amazonensis Leading to Oxidative Stress, Growth Arrest, and Ultrastructural Alterations

  2022cites this paper
• Furan derivatives impair proliferation and affect ultrastructural organization of Trypanosoma cruzi and Leishmania amazonensis.

  2021cites this paper
• Cutaneous leishmaniasis due to Leishmania aethiopica: A therapeutic challenge

  2021cites this paper
• Leishmanicidal and cytotoxic activity of essential oil from the fruit peel of Myrciaria floribunda (H. West ex Willd.) O. Berg: Molecular docking and molecular dynamics simulations of its major constituent onto Leishmania enzyme targets

  2021cites this paper
• Synthesis and biological activity of novel 4-aminoquinoline/1,2,3-triazole hybrids against Leishmania amazonensis.

  2021cites this paper
• Unravelling the myth surrounding sterol biosynthesis as plausible target for drug design against leishmaniasis

  2021cites this paper
• Acarbose presents in vitro and in vivo antileishmanial activity against Leishmania infantum and is a promising therapeutic candidate against visceral leishmaniasis

  2021cites this paper
• Antileishmanial activity of 4-phenyl-1-[2-(phthalimido-2-yl)ethyl]-1H-1,2,3-triazole (PT4) derivative on Leishmania amazonensis and Leishmania braziliensis: In silico ADMET, in vitro activity, docking and molecular dynamic simulations.

  2020cites this paper
• Synthesis and Biological Activity of Novel Zinc-Itraconazole Complexes in Protozoan Parasites and Sporothrix spp

  2020influential citation
• Synthesis and trypanocidal activity of novel pyridinyl-1,3,4-thiadiazole derivatives.

  2020cites this paper
• New applications of squalene synthase inhibitors: Membrane cholesterol as a therapeutic target

  2020cites this paper
• In Vitro Effect of Pitavastatin and Its Synergistic Activity with Isavuconazole against Acanthamoeba castellanii

  2020cites this paper
• Biological activity of monoquaternary ammonium compounds based on 3-substituted quinuclidine: A short review

  2020cites this paper
• Enabling Heterologous Synthesis of Lupulones in the Yeast Saccharomyces cerevisiae

  2019cites this paper
• Discovery of novel quaternary ammonium compounds based on quinuclidine-3-ol as new potential antimicrobial candidates.

  2019cites this paper
• Atividade Antifúngica do Látex de Jatropha multifida L. (Euphorbiaceae) e de Lupenona isolada de suas Folhas

  2019cites this paper
• Recent progress in drug targets and inhibitors towards combating leishmaniasis.

  2018cites this paper
• Chemical composition of Ocimum canum Sims. essential oil and the antimicrobial, antiprotozoal and ultrastructural alterations it induces in Leishmania amazonensis promastigotes

  2018cites this paper
• Enzymatic chokepoints and synergistic drug targets in the sterol biosynthesis pathway of Naegleria fowleri

  2018cites this paper
• Isobenzofuranone derivative JVPH3, an inhibitor of L. donovani topoisomerase II, disrupts mitochondrial architecture in trypanosomatid parasites

  2018cites this paper
• In vitro antileishmanial activity of ravuconazole, a triazole antifungal drug, as a potential treatment for leishmaniasis

  2018cites this paper
• CYP51 is an essential drug target for the treatment of primary amoebic meningoencephalitis (PAM)

  2017cites this paper
• Benzimidazole derivatives endowed with potent antileishmanial activity

  2017cites this paper
• Selenium-containing analogues of WC-9 are extremely potent inhibitors of Trypanosoma cruzi proliferation.

  2017cites this paper
• Antileishmanial Efficacy and Pharmacokinetics of DB766-Azole Combinations

  2017cites this paper
• Effect of 1,2,3-triazole salts, non-classical bioisosteres of miltefosine, on Leishmania amazonensis.

  2017cites this paper
• Antileishmanial effects of the alkaloid-rich fraction of Quassia amara L.

  2016cites this paper
• Synthesis and pharmacological evaluation of mono-arylimidamides as antileishmanial agents

  2016cites this paper
• Antileishmanial Activity of Ezetimibe: Inhibition of Sterol Biosynthesis, In Vitro Synergy with Azoles, and Efficacy in Experimental Cutaneous Leishmaniasis

  2016cites this paper